Taxus produces similar outcomes in men & women
Results of a gender-specific study to assess the efficacy of the Taxus paclitaxel-eluting coronary stent in women undergoing coronary revascularisation were released at the European Society of Cardiology Congress by interventional device developer Boston Scientific.
Named Taxus Woman, the study indicates that paclitaxel-eluting stents have similar clinical outcomes in women and men, despite the higher risk profile in female patients.
The researchers analysed pooled results of women enrolled in trials to evaluate the performance of the Taxus stent compared with a bare-metal stent used in control patients with coronary artery disease. The women’s results were compared with the corresponding endpoints in men.
According to the Massachusetts-based firm, there were no other significant differences in baseline demographics, and lesion or procedural characteristics between the Taxus and bare-metal stent groups in both genders.
This article was published on 10/30/2007
Search
Service
Company News
Accu-Chek® Combo – put effective diabetes management into action
At the annual congress of the European Association for the Study of Diabetes (EASD) this year in Rome, Roche Diabetes Care introduced Accu-Chek Combo – the insulin pump system that combines an insulin pump with an intelligent glucose monitoring system, a bolus calculator, and an integrated pump remote-control.
Meet us at MEDICA! Hall 7 Stand 15
The European Hospital team will be happy to hear about your research, products, R&D or trials and launches, hospital management issues, or any other aspects of your work, so that we can discuss your editorial ideas. We will also be pleased to help with any PR or advertising queries.
Products redesigned to help patients simplify life with diabetes
Bayer HealthCare Diabetes Care unveiled the new
CONTOUR® blood glucose meter with enhanced testing features at the 44th Annual Meeting of the European Association for the Study of Diabetes in Rome, Italy.
